Bank of America
XENE icon

Bank of America’s Xenon Pharmaceuticals XENE Stock Holding History

Bank of America’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-116,900
Closed -$5.38M – 8241
2023
Q4 		$5.38M Buy
+116,900
New +$4.13M ﹤0.01% 3490

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America's XENE Position: Q1 2026 in Review

Bank of America increased its Xenon Pharmaceuticals (XENE) stake by 20% in Q1 2026, buying an estimated $2.02M and bringing the position to 265,267 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Bank of America first reported a position in XENE in Q4 2014 and has held it in 31 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Bank of America held 265,267 shares of Xenon Pharmaceuticals worth $15.4M as of Q1 2026.
  • Bank of America bought 43,899 Xenon Pharmaceuticals shares in Q1 2026, an estimated $2.02M.
  • Xenon Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2600 holding.
  • Bank of America first reported a position in Xenon Pharmaceuticals in Q4 2014 and has held it in 31 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.